Evidence map›Paper›PMID 34777840›Full record

ArticleNeuro-oncology practice2021

Variations in the management of diffuse low-grade gliomas-A Scandinavian multicenter study.

Bodil Karoline Ravn Munkvold, Ole Solheim, Jiri Bartek, Alba Corell, Eddie de Dios, Sasha Gulati, Eirik Helseth, Klas Holmgren, Margret Jensdottir, Mina Lundborg and 17 more

Abstract read
In one paragraph

Article in Neuro-oncology practice, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Observational
  5. Brain stimulation and elicited memories.Acta neurochirurgica · 2023
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Bodil Karoline Ravn MunkvoldDepartment of Neuromedicine and Movement Science, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, NTNU, Trondheim, Norway.ORCID https://orcid.org/0000-0002-0442-9424
Ole SolheimDepartment of Neuromedicine and Movement Science, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, NTNU, Trondheim, Norway.
Jiri BartekDepartment of Neurosurgery, Karolinska University Hospital, Stockholm, Sweden.
Alba CorellInstitute of Neuroscience and Physiology, Sahlgrenska Academy, Gothenburg, Sweden.ORCID https://orcid.org/0000-0002-6329-2392
Eddie de DiosDepartment of Neurosurgery, Sahlgrenska University Hospital, Gothenburg, Sweden.
Sasha GulatiDepartment of Neuromedicine and Movement Science, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, NTNU, Trondheim, Norway.
Eirik HelsethDepartment of Neurosurgery, Oslo University Hospital, Oslo, Norway.
Klas HolmgrenDepartment of Clinical Sciences, Neuroscience, Umeå University, Umeå, Sweden.
Margret JensdottirDepartment of Neurosurgery, Karolinska University Hospital, Stockholm, Sweden.
Mina LundborgDepartment of Neurosurgery, Oslo University Hospital, Oslo, Norway.
Eduardo Erasmo Mendoza MirelesDepartment of Neurosurgery, Oslo University Hospital, Oslo, Norway.
Ruby MahesparanDepartment of Clinical Medicine, Faculty of Medicine, University of Bergen, Bergen, Norway.
Øystein Vesterli TveitenDepartment of Clinical Medicine, Faculty of Medicine, University of Bergen, Bergen, Norway.
Peter MilosDepartment of Neurosurgery, Linköping University Hospital, Sweden.
Henrietta Nittby RedebrandtDepartment of Clinical Sciences, Lund University, Lund, Sweden.
Lars Kjelsberg PedersenDepartment of Neurosurgery, University Hospital of North Norway, Tromsø, Norway.
Jon Ramm-PettersenDepartment of Neurosurgery, Oslo University Hospital, Oslo, Norway.
Rickard L SjöbergDepartment of Clinical Sciences, Neuroscience, Umeå University, Umeå, Sweden.
Björn SjögrenDepartment of Neurosurgery, Linköping University Hospital, Sweden.
Kristin SjåvikDepartment of Neurosurgery, University Hospital of North Norway, Tromsø, Norway.
Anja SmitsInstitute of Neuroscience and Physiology, Sahlgrenska Academy, Gothenburg, Sweden.
Gregor TomasevicDepartment of Neurosurgery, Skåne University Hospital, Lund, Sweden.
Tomás Gómez VecchioInstitute of Neuroscience and Physiology, Sahlgrenska Academy, Gothenburg, Sweden.
Einar O Vik-MoDepartment of Neurosurgery, Oslo University Hospital, Oslo, Norway.
Maria ZetterlingDepartment of Neuroscience, Uppsala University, Uppsala, Sweden.
Øyvind SalvesenDepartment of Public Health and Nursing, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.
Asgeir S JakolaDepartment of Neurosurgery, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEarly extensive surgery is a cornerstone in treatment of diffuse low-grade gliomas (DLGGs), and an additional survival benefit has been demonstrated from early radiochemotherapy in selected "high-risk" patients. Still, there are a number of controversies related to DLGG management. The objective of this multicenter population-based cohort study was to explore potential variations in diagnostic work-up and treatment between treating centers in 2 Scandinavian countries with similar public health care systems.

methodsPatients screened for inclusion underwent primary surgery of a histopathologically verified diffuse WHO grade II glioma in the time period 2012 through 2017. Clinical and radiological data were collected from medical records and locally conducted research projects, whereupon differences between countries and inter-hospital variations were explored.

resultsA total of 642 patients were included (male:female ratio 1:4), and annual age-standardized incidence rates were 0.9 and 0.8 per 100 000 in Norway and Sweden, respectively. Considerable inter-hospital variations were observed in preoperative work-up, tumor diagnostics, surgical strategies, techniques for intraoperative guidance, as well as choice and timing of adjuvant therapy.

conclusionsDespite geographical population-based case selection, similar health care organizations, and existing guidelines, there were considerable variations in DLGG management. While some can be attributed to differences in clinical implementation of current scientific knowledge, some of the observed inter-hospital variations reflect controversies related to diagnostics and treatment. Quantification of these disparities renders possible identification of treatment patterns associated with better or worse outcomes and may thus represent a step toward more uniform evidence-based care.

Indexed as

adjuvantchemotherapydiagnostic imaginggliomaradiotherapysurgical oncology

Identifiers

PMID34777840
PMCPMC8579093

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.